Accuro Epidural Guidance Device Demonstrated Superior for Spinal Anesthesia Administration Compared to Palpation & Conventional Ultrasound in a Parturient With Extreme Obesity
16. August 2022 06:00 ET
|
RIVANNA (rivannamedical.com)
CHARLOTTESVILLE, Va., Aug. 16, 2022 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, announced the results of a clinical case study demonstrating that Accuro...
Bupivacaine Injection Market to Reach USD 1447 Million by 2030: Straits Research
08. April 2022 08:15 ET
|
Straits Research
New York, United States, April 08, 2022 (GLOBE NEWSWIRE) -- The global bupivacaine injection market had a market share of USD 721.68 million in 2017, according to a new report of StraitsResearch. It...
B. Braun Will Showcase Clorotekal® (chloroprocaine hydrochloride) at ASRA 2019
04. April 2019 13:36 ET
|
B. Braun Medical Inc.--US
BETHLEHEM, Pa., April 04, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. will present its first FDA-approved local anesthetic for spinal anesthesia -- Clorotekal® (chloroprocaine hydrochloride) --...